Hypouricemia in individuals admitted to an inpatient hospital-based facility

American Journal of Kidney Diseases

Volumn 41, Issue 6, 2003, Pages 1225-1232

  Bairaktari, Eleni T ^b   Kakafika, Anna I ^b   Pritsivelis, Nikos ^b   Hatzidimou, Katerina G ^b   Tsianos, Epameinondas V ^b   Seferiadis, Konstantin I ^b   Elisaf, Moses S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b NONE

Author keywords

Glucosuria; Hypokalemia; Hypophosphatemia; Hypouricemia; Urinary urate wasting

Indexed keywords

ALLOPURINOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; COTRIMOXAZOLE; FENOFIBRATE; LOSARTAN; PHOSPHATE; POTASSIUM; URIC ACID;

ARTICLE; BRAIN DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSURIA; HEMATOLOGIC MALIGNANCY; HOMEOSTASIS; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERURICOSURIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOURICEMIA; INCIDENCE; INTERNAL MEDICINE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; OBSTRUCTIVE JAUNDICE; PATHOGENESIS; PATHOPHYSIOLOGY; PHOSPHATURIA; POTASSIUM URINE LEVEL; PREVALENCE; SOLID TUMOR; URIC ACID BLOOD LEVEL; URINARY EXCRETION;

EID: 0037762865     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(03)00355-X     Document Type: Article

References (53)

1. Maesaka JK, Fishbane S: Regulation of renal urate excretion: A critical review. Am J Kidney Dis 32:917-933, 1998
2. Ogino K, Hisatome I, Saitoh M, et al: Clinical significance of hypouricemia in hospitalized patients. J Med 22:76-82, 1991
3. Ramsdell CM, Kelley WN: The clinical significance of hypouricemia. Ann Intern Med 78:239-242, 1973
4. Crook M: Hypouricemia in a hospital population. Scand J Clin Lab Med 53:883-885, 1993
5. Yanase M, Nakahama H, Mikami H, Fukuhara Y, Orita Y, Yoshikawa H: Prevalence of hypouricemia in apparently normal population. Nephron 48:80, 1988
6. Van Peenen HJ: Causes of hypouricemia. Ann Intern Med 78:977-978, 1973
7. Maesaka JK, Cusano AJ, Thies HL, Siegal FP, Dreisbach AW: Hypouricemia in acquired immunodeficiency syndrome. Am J Kidney Dis 15:252-257, 1990
8. Elisaf M, Tsimichodimos V, Bairaktari E, Siamopoulos KC: Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia. J Cardiovasc Pharmacol 34:60-63, 1999
9. Liberopoulos E, Elisaf M: Cotrimoxazole-induced hypouricemia. Clin Nephrol 49:202, 1998
10. Elisaf M, Panteli K, Theodorou I, Siamopoulos KC: Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res 10:315-320, 1997
11. Bianchetti MG, Kanaka C, Ridolfi-Luthy A, et al: Chronic renal magnesium loss, hypocalciuria and mild hypokalaemic metabolic alkalosis after cisplatin. Pediatr Nephrol 4:219-222, 1990
12. De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E: Renal tubular dysfunction in chronic alcohol abuse - Effects of abstinence. N Engl J Med 329:1927-1934, 1993
13. Narins RG, Jones ER, Stom MC, Rudnick MR, Bastl CP: Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis. Am J Med 72:496-520, 1982
14. Elisaf M, Siamopoulos KC: Fractional excretion of potassium in normal subjects and in patients with hypokalemia. Postgrad Med J 71:211-212, 1995
15. Rossi R, Danzebrink S, Linnenbürger K, et al: Assessment of tubular reabsorption of sodium, glucose, phosphate and amino acids based on spot urine samples. Acta Paediatr 83:1282-1286, 1994
16. Bairaktari E, Liamis G, Tsolas O, Elisaf M: Partially reversible renal tubular damage in patients with obstructive jaundice. Hepatology 33:1365-1369, 2001
17. Bartter FC, Schwartz WB: The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 42:790-806, 1967
18. Newman DJ, Pugia MJ, Lott JA, Wallace JF, Hiar AM: Urinary protein and albumin excretion corrected by creatinine and specific gravity. Clin Chim Acta 294:139-155, 2000
19. Lesmes A, Diaz-Curiel M, Castrillo JM: Tumoural hypouricemia. Adv Exp Med Biol 122A:145-148, 1980
20. Magoula I, Tsapas G, Koutouras I, Paletas K: Cholangiocarcinoma and severe renal hypouricemia: A study of the renal mechanisms. Am J Kidney Dis 18:514-519, 1991
21. Magoula I, Tsapas G, Garyfallos A, Kountouras J: Hypouricemia in liver cell carcinoma: An isolated renal tubular defect. Am J Med 83:196-197, 1987
22. Kelley WN: Hypouricemia. Arthritis Rheum 18:731-737, 1980
23. Liamis G, Elisaf M: Hypokalemia, hypophosphatemia and hypouricemia due to proximal renal tubular dysfunction in acute myeloid leukemia. Eur J Haematol 64:277-278, 2000
24. Mir MA, Delamore IW: Hypouricemia and proximal renal tubular dysfunction in acute myeloid leukaemia. Br Med J 3:775-777, 1974
25. Milionis HJ, Bourantas CL, Siamopoulos KC, Elisaf MS: Acid-base and electrolyte abnormalities in patients with acute leukemia. Am J Hematol 62:201-207, 1999
26. Shichiri M, Iwamoto H, Shiigai T: Diabetic renal hypouricemia. Arch Intern Med 147:225-228, 1987
27. Magoula I, Tsapas G, Paletas K, Mavromatidis K: Insulin-dependent diabetes and renal hypouricemia. Nephron 59:21-26, 1991
28. Bonones RW, Dana ES: On the increased uric acid clearance following the intravenous infusion of hypertonic glucose solution. J Clin Invest 25:386-388, 1946
29. Christensen PJ, Steenstrup OR: Uric acid excretion with increasing plasma glucose concentration (pregnant and nonpregnant cases). Scand J Clin Lab Invest 10:182-185, 1958
30. Gonzalez-Sicilia L, Garcia-Estan J, Martinez-Blazquez A, Fernandez-Pardo J, Quiles JL, Hernandez J: Renal metabolism of uric acid in type I insulin-dependent diabetic patients: Relation to metabolic compensation. Horm Metab Res 29:520-523, 1997
31. Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G: Hypouricemia and hyperuricemia in type 2 diabetes: Two different phenotypes. Eur J Clin Invest 31:318-321, 2001
32. Maesaka JK, Venkatesan J, Piccione JM, Decker R, Dreisbach AW, Wetherington J: Abnormal urate transport in patients with intracranial disease. Am J Kidney Dis 19:10-15, 1992
33. Liamis G, Bairaktari E, Elisaf M: Effect of fenofibrate on serum uric acid levels. Am J Kidney Dis 34:594-595, 1999
34. Edwards RM, Trizna W, Stack EJ, Weinstock J: Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes. J Pharmacol Exp Ther 276:125-129, 1996
35. Nikas S, Rizos E, Milionis H, et al: The effects of the addition of losartan on uric acid metabolism in patients receiving indapamide. J Renin Angiotensin Aldosterone Syst 1:289-291, 2000
36. Liamis G, Alexandridis G, Bairaktari E, Elisaf M: Aminoglycoside-induced metabolic abnormalities. Ann Clin Biochem 37:543-544, 2000
37. Steele TH: Evidence for altered renal urate reabsorption during changes in volume of the extracellular fluid. J Lab Clin Med 74:288-299, 1969
38. Diamond H, Meisel A: Influence of volume expansion, serum sodium, and fractional excretion of sodium on urate excretion. Pflugers Arch 356:47-57, 1975
39. Cannon PJ, Svahn DS, Demartini FE: The influence of hypertonic saline infusions upon the fractional reabsorption of urate and other ions in normal and hypertensive man. Circulation 41:97-108, 1970
40. Manuel MA, Steele TH: Pyrazinamide suppression of the uricosuric response to sodium chloride infusion. J Lab Clin Med 83:417-427, 1974
41. Seguro AC, Lomar AV, Rocha AS: Acute renal failure of leptospirosis: Nonliguric and hypokalemic forms. Nephron 55:146-151, 1990
42. Magaldi AJ, Yasuda PN, Kudo LH, Seguro AC, Rocha AS: Renal involvement in leptospirosis: A pathophysiologic study. Nephron 62:332-339, 1992
43. Liamis G, Rizos E, Elisaf M: Reversible proximal tubular dysfunction in a patient with acute febrile illness and normal renal function: An evidence towards leptospirosis. Clin Nephrol 53:316, 2000
44. Nakou K, Liamis G, Elisaf MS, Siamopoulos KC: Low normal potassium levels in acute renal failure: Evidence of leptospirosis. Infection 28:196, 2000
45. Tsimihodimos V, Kalaitzides R, Elisaf M: Hypouricemia in a patient with thyrotoxicosis. Eur J Endocrinol 144:83, 2001
46. Alexandridis G, Liamis G, Elisaf M: Reversible tubular dysfunction that mimicked Fanconi's syndrome in a patient with anorexia nervosa. Int J Eat Disord 30:227-230, 2001
47. Mancias P, Kramer L, Butler IJ: Amoxapine overdose in a young man: A transient mitochondrial abnormality? Pharmacotherapy 15:528-532, 1995
48. Kreisel W, Wolf LM, Grotz W, Grieshaber M: Renal tubular damage: An extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 8:461-468, 1996
49. Winstanley PA, Young JB, Axon AT, Brownjohn AM, Cooper EH: Renal proximal tubular dysfunction in Crohn's disease. Br Med J 288:1612-1613, 1984
50. Hamling J, Raedler A, Helmchen U, Schreiber S: 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Digestion 58: 304-307, 1997
51. Alexandridis G, Pappas GA, Elisaf MS: Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil. Am J Med 109:261-262, 2000
52. Bairaktari E, Seferiadis K, Liamis G, Psihogios N, Tsolas O, Elisaf M: Rhabdomyolysis-related renal tubular damage studied by proton nuclear magnetic resonance spectroscopy of urine. Clin Chem 48:1106-1109, 2002
53. Enomoto A, Kimura H, Chairoungdua A, et al: Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417:447-452, 2002